Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: A critical review of the literature for the RENOVATE study protocol.


Journal

Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049

Informations de publication

Date de publication:
May 2023
Historique:
received: 01 12 2022
revised: 06 02 2023
accepted: 13 02 2023
medline: 28 4 2023
pubmed: 18 3 2023
entrez: 17 3 2023
Statut: ppublish

Résumé

Liquid biopsy has the potential to drastically change clinical practice, paving the way to a novel non-invasive approach for cancer diagnosis and treatment. One of the limitations for the implementation of liquid biopsy in clinical practice is the lack of shared and reproducible standard operating procedures (SOPs) for sample collection, processing and storage. Here, we present a critical review of the literature focusing on the available SOPs to guide liquid biopsy management in research settings and describe SOPs that our laboratory developed and employed in the context of a prospective clinical-translational trial (RENOVATE, NCT04781062). The main aim of this manuscript is to address common issues, towards the implementation of interlaboratory shared protocols for optimized preanalytical handling of blood and urine samples. To our knowledge, this work is one of the few up-to-date, freely available comprehensive reports on trial-level procedures for the handling of liquid biopsy.

Identifiants

pubmed: 36931614
pii: S1040-8428(23)00051-3
doi: 10.1016/j.critrevonc.2023.103963
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103963

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest The authors declare no conflict of interest.

Auteurs

Martina Dameri (M)

Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, 16132 Genoa, Italy.

Gabriella Cirmena (G)

IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Francesco Ravera (F)

Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, 16132 Genoa, Italy; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, 10044 New York, NY, USA.

Lorenzo Ferrando (L)

IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Paola Cuccarolo (P)

Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, 16132 Genoa, Italy.

Mario Stabile (M)

Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, 16132 Genoa, Italy.

Giuseppe Nicolò Fanelli (GN)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, 10021 New York, NY, USA; First Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.

Pier Vitale Nuzzo (PV)

Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, 10044 New York, NY, USA.

Massimo Calabrese (M)

IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Alberto Tagliafico (A)

IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy; Department of Health Sciences (DISSAL), University of Genoa, 16132, Genoa, Italy.

Alberto Ballestrero (A)

Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, 16132 Genoa, Italy; IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.

Gabriele Zoppoli (G)

Department of Internal Medicine and Medical Specialties (DiMI), University of Genoa, 16132 Genoa, Italy; IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy. Electronic address: gabriele.zoppoli@unige.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH